SVC stenting for treatment of malignant obstruction – online course
Authors: A. Mahnken and H. Moriarty
Reviewers: D. Filippiadis, M. Hoffmann, G. Mauri, C. Nice and D. Tsetis
Obstruction of the superior vena cava (SVC), in the modern era, occurs most frequently in malignancy, with bronchogenic carcinoma accounting for at least 50% of causes. Presentation may be as a medical emergency, with features of respiratory or CNS depression, or more indolent in nature. The severity and duration of symptoms of SVC obstruction (SVCO) are an important guide to the timing of intervention. Charnsangavej et al. in 1986 described an endovascular approach for the treatment of SVCO. Percutaneous stenting of the SVC is a minimally invasive proceedure which allows rapid alleviation of symptoms without interfering with tumour treatment.
- To learn about pathophysiology and clinical presentation of malignant SVC obstruction
- To learn about techniques of SVC stenting
- To learn about patient management and post-procedural care in patients with malignant SVC obstruction
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the EBIR curriculum and corresponds to chapter 22.214.171.124.3 Disease of the Superior and Inferior Vena Cava.
The format of the course is easy to use and interactive by including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC).
Upon purchase, access to complete and revisit the course is granted for an enrolment period of 90 days. The certificate of completion will be available beyond the enrolment period in the new myCIRSE area.
Release date: November 2018